smaller biotechnology companies is more logical than large purchases at the premiums paid in drug industry deals like Pfizer Inc.���s $68 billion acquisition of Wyeth in 2009, Dekkers said. Earnings Multiple Companies have paid a median 13.3 times...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Bayer CEO Says He���s Open to Health Unit ���Merger of Equals���
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account